271 |
Biodegradable Stents |
Maurice Buchbinder |
Jun. 01. 07 |
270 |
The Results of the E-Janus Registry of 2,500 Patients (SORIN) |
Jacques J. Koolen |
Jun. 01. 07 |
269 |
Nobori Stent, Update |
Seung-Jung Park |
Jun. 01. 07 |
268 |
PCI for Left Main & Multivessel CAD: The SYNTAX Trial |
Ted Feldman |
Jun. 01. 07 |
267 |
12-Months Follow-Up of TAXUS & Cypher Stent; Results from the MAHI Database |
Barry D. Rutherford |
Jun. 01. 07 |
266 |
Drug-Eluting Stents: Are They Equal in Efficacy and Safety? |
Albert Schömig |
Jun. 01. 07 |
265 |
Should Everybody Get DES? |
Augusto D. Pichard |
Jun. 01. 07 |
264 |
REWARDS: Non- Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents in the Real World: 1-Year Results From a Large, Single Center Registry |
Ron Waksman |
May. 25. 07 |
263 |
ACUITY: One Year Outcome of ACUITY Trial |
Roxana Mehran |
May. 25. 07 |
262 |
ZOMAXX I: A Prospective, Multicenter, Randomized Trial of Zotarolimus-Eluting and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease: 9-Month Clinical and Angiographic Results |
Bernard R. Chevalier |
May. 25. 07 |